K
Kelly W. Maloney
Researcher at University of Colorado Denver
Publications - 117
Citations - 3839
Kelly W. Maloney is an academic researcher from University of Colorado Denver. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 31, co-authored 106 publications receiving 2847 citations. Previous affiliations of Kelly W. Maloney include University of Florida & United States Department of Health and Human Services.
Papers
More filters
Journal ArticleDOI
PAX5 -driven subtypes of B-progenitor acute lymphoblastic leukemia
Zhaohui Gu,Michelle L. Churchman,Kathryn G. Roberts,Ian Moore,Xin Zhou,Joy Nakitandwe,Kohei Hagiwara,Stephane Pelletier,Sebastien Gingras,Hartmut Berns,Debbie Payne-Turner,Ashley Hill,Ilaria Iacobucci,Lei Shi,Stanley Pounds,Cheng Cheng,Deqing Pei,Chunxu Qu,Scott Newman,Meenakshi Devidas,Yunfeng Dai,Shalini C. Reshmi,Julie M. Gastier-Foster,Elizabeth A. Raetz,Michael J. Borowitz,Brent L. Wood,William L. Carroll,Patrick A. Zweidler-McKay,Karen R. Rabin,Leonard A. Mattano,Kelly W. Maloney,Alessandro Rambaldi,Orietta Spinelli,Jerald P. Radich,Mark D. Minden,Jacob M. Rowe,Selina M. Luger,Mark R. Litzow,Martin S. Tallman,Janis Racevskis,Yanming Zhang,Ravi Bhatia,Jessica Kohlschmidt,Krzysztof Mrózek,Clara D. Bloomfield,Wendy Stock,Steven M. Kornblau,Hagop M. Kantarjian,Marina Konopleva,Williams E. Evans,Sima Jeha,Ching-Hon Pui,Jun J. Yang,Elisabeth Paietta,James R. Downing,Mary V. Relling,Jinghui Zhang,Mignon L. Loh,Stephen P. Hunger,Charles G. Mullighan +59 more
TL;DR: Analysis of 1,988 cases of B-cell acute lymphoblastic leukemia characterizes 23 subtypes defined by genomic features and shows that two of the subtypes have frequent PAX5 alterations, demonstrating the utility of transcriptome sequencing to classify B-ALL.
Journal ArticleDOI
Diarrhoea prevention in Bolivia through point-of-use water treatment and safe storage: a promising new strategy.
Robert Quick,L. V. Venczel,E. D. Mintz,L. Soleto,J. Aparicio,M. Gironaz,L. Hutwagner,K. Greene,C. A. Bopp,Kelly W. Maloney,D. Chavez,Mark D. Sobsey,R. V. Tauxe +12 more
TL;DR: A novel water quality intervention that consists of point-of-use water disinfection, safe storage and community education was field tested in Bolivia and found it to have broad applicability for waterborne disease prevention.
Journal ArticleDOI
Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia
Zhaohui Gu,Michelle L. Churchman,Kathryn G. Roberts,Yanhong Li,Yu Liu,Richard C. Harvey,Kelly McCastlain,Shalini C. Reshmi,Debbie Payne-Turner,Ilaria Iacobucci,Y Shao,I-Ming Chen,Marcus B. Valentine,Deqing Pei,K. Mungall,Andrew J. Mungall,Yussanne Ma,Richard A. Moore,Marco A. Marra,Eileen Stonerock,Julie M. Gastier-Foster,Julie M. Gastier-Foster,Meenakshi Devidas,Yunfeng Dai,Brent L. Wood,Michael J. Borowitz,EE Larsen,Kelly W. Maloney,Leonard A. Mattano,Anne L. Angiolillo,Wanda L. Salzer,Michael J. Burke,F Gianni,Orietta Spinelli,Jerald P. Radich,Minden,Anthony V. Moorman,Bella Patel,Adele K. Fielding,Jacob M. Rowe,Selina M. Luger,Ravi Bhatia,I Aldoss,S.J. Forman,Jessica Kohlschmidt,Krzysztof Mrózek,Guido Marcucci,Clara D. Bloomfield,Wendy Stock,Steven M. Kornblau,Hagop M. Kantarjian,Marina Konopleva,Elisabeth Paietta,Cheryl L. Willman,Mignon L. Loh,Stephen P. Hunger,Charles G. Mullighan +56 more
TL;DR: MEF2D-rearranged ALL represents a distinct form of high-risk leukaemia, for which new therapeutic approaches should be considered.
Journal ArticleDOI
6MP adherence in a multiracial cohort of children with acute lymphoblastic leukemia: a Children's Oncology Group study
Smita Bhatia,Wendy Landier,Lindsey Hageman,Heeyoung Kim,Yanjun Chen,Kristine R. Crews,William E. Evans,Bruce Bostrom,Jacqueline Casillas,David S. Dickens,Kelly W. Maloney,Joseph P. Neglia,Yaddanapudi Ravindranath,A. Kim Ritchey,F. Lennie Wong,Mary V. Relling +15 more
TL;DR: This study identifies race-specific determinants of adherence, and defines a clinically relevant level of adherence needed to minimize relapse risk in a multiracial cohort of children with ALL.
Journal ArticleDOI
Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL
Brent L. Wood,David Wu,Beryl Crossley,Yunfeng Dai,David Williamson,Charles Gawad,Michael J. Borowitz,Meenakshi Devidas,Kelly W. Maloney,Eric Larsen,Naomi J. Winick,Elizabeth A. Raetz,William L. Carroll,Stephen P. Hunger,Mignon L. Loh,Harlan Robins,Ilan R. Kirsch +16 more
TL;DR: The higher analytic sensitivity and lower false-negative rate of HTS improves upon FC for MRD detection in pediatric B-ALL by identifying a novel subset of patients at end of induction who are essentially cured using current chemotherapy and identifying MRD at 0.01% in up to one-third of patients who are missed at the same threshold by FC.